Russian Direct Investment Fund
- All
- News
- Videos
-
Russia May Launch Sputnik Light Covid Vaccine In India By Next Month
The Russian Direct Investment Fund today informed that Sputnik light COVID-19 vaccine will likely be launched in India by December this year.
-
Mixing AstraZeneca, Sputnik Shows "No Serious Adverse Effects": Report
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces initial safety results of the world's first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine.
-
Morepen Labs In Himachal Starts Production Of Test Batch Of Sputnik V Vaccine
Morepen Laboratories has started production of the test batch of Russia's Sputnik V COVID-19 vaccine at its facility in Himachal Pradesh, Russian Direct Investment Fund (RDIF) and the domestic drug firm said in a statement on Tuesday.
-
Sputnik V To Offer Booster Shots Against Delta Variant To Other Vaccine Makers
The Russian Direct Investment Fund today said its Covid vaccine Sputnik V will soon offer a booster shot or the second dose of the vaccine, which has been adjusted to work against the Delta variant of coronavirus, to other vaccine manufacturers.
-
Sputnik Light Covid Vaccine Shows 78.6-83.7% Efficacy Among Elderly: Russian Maker
The Russian Direct Investment Fund (RDIF) on Wednesday announced that the Russian Sputnik Light coronavirus vaccine demonstrates 78.6-83.7 per cent efficacy among the elderly.
-
COVID-19 Vaccine Sputnik V Production Launched In India
Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund has begun the production of Sputnik V COVID-19 vaccine in India, according to a joint statement issued today.
-
Mumbai Gets 3 Bids From Russia's Sputnik Covid Vaccine Makers
The London-based facilitator of the Russian Direct Investment Fund and its India-based independent representatives have together made three bids for the supply of one crore Sputnik V Covid vaccine doses to the Mumbai civic body.
-
1st Lot Of Russian COVID-19 Vaccine Sputnik V Likely In India By May End
Dr Reddy's Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccine Sputnik V, today said it expects the first lot of stock from Russian Direct Investment Fund by May end.
-
Sputnik More Effective Against Mutations, Says Russian Maker. Here's Why
Russia's Sputnik V, the third Covid vaccine to be cleared for use in India, is effective against mutant strains, the Russian Direct Investment Fund (RDIF) has said.
-
India's Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Yearly: Report
Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
-
Hyderabad-Based Virchow Biotech To Produce Sputnik V Vaccine In India
Russian Direct Investment Fund (RDIF) and Hyderabad-based Virchow Biotech on Monday announced an agreement to produce up to 200 million doses of Sputnik V vaccine in India.
-
India's Gland Pharma To Produce Up To 252 Million Doses For Russia's Sputnik V Vaccine
India's Gland Pharma Ltd said on Tuesday it has entered into an agreement with the Russian Direct Investment Fund (RDIF) to produce and supply up to 252 million doses of the Sputnik V COVID-19 vaccine.
-
Russia Expects India To Approve Sputnik V Vaccine For Use Soon: Report
India is expected to grant emergency use authorization for Russia's Sputnik V COVID-19 vaccine this month or next, the Russian Direct Investment Fund (RDIF), which markets the shot abroad, told ANI on Tuesday.
-
Russian Covid Vaccine In Phase 3 Trial, To Cost Less Than $10 Per Dose In India
The Russian COVID-19 vaccine "Sputnik V" will cost less than USD 10 (about Rs 730) per shot in India and the price is the same for all countries, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF) said on Thursday.
-
Sputnik V Can Be "Highly Effective" Against New Covid Strain: Co-Developer
Sputnik V, the world's first COVID-19 vaccine, will be "highly effective" against the new strain of coronavirus found in Europe, said Kirill Dmitriev, Chief Executive Officer (CEO) of Russian Direct Investment Fund, the company which co-developed the vaccine.
-
Russia May Launch Sputnik Light Covid Vaccine In India By Next Month
The Russian Direct Investment Fund today informed that Sputnik light COVID-19 vaccine will likely be launched in India by December this year.
-
Mixing AstraZeneca, Sputnik Shows "No Serious Adverse Effects": Report
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces initial safety results of the world's first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine.
-
Morepen Labs In Himachal Starts Production Of Test Batch Of Sputnik V Vaccine
Morepen Laboratories has started production of the test batch of Russia's Sputnik V COVID-19 vaccine at its facility in Himachal Pradesh, Russian Direct Investment Fund (RDIF) and the domestic drug firm said in a statement on Tuesday.
-
Sputnik V To Offer Booster Shots Against Delta Variant To Other Vaccine Makers
The Russian Direct Investment Fund today said its Covid vaccine Sputnik V will soon offer a booster shot or the second dose of the vaccine, which has been adjusted to work against the Delta variant of coronavirus, to other vaccine manufacturers.
-
Sputnik Light Covid Vaccine Shows 78.6-83.7% Efficacy Among Elderly: Russian Maker
The Russian Direct Investment Fund (RDIF) on Wednesday announced that the Russian Sputnik Light coronavirus vaccine demonstrates 78.6-83.7 per cent efficacy among the elderly.
-
COVID-19 Vaccine Sputnik V Production Launched In India
Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund has begun the production of Sputnik V COVID-19 vaccine in India, according to a joint statement issued today.
-
Mumbai Gets 3 Bids From Russia's Sputnik Covid Vaccine Makers
The London-based facilitator of the Russian Direct Investment Fund and its India-based independent representatives have together made three bids for the supply of one crore Sputnik V Covid vaccine doses to the Mumbai civic body.
-
1st Lot Of Russian COVID-19 Vaccine Sputnik V Likely In India By May End
Dr Reddy's Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccine Sputnik V, today said it expects the first lot of stock from Russian Direct Investment Fund by May end.
-
Sputnik More Effective Against Mutations, Says Russian Maker. Here's Why
Russia's Sputnik V, the third Covid vaccine to be cleared for use in India, is effective against mutant strains, the Russian Direct Investment Fund (RDIF) has said.
-
India's Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Yearly: Report
Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
-
Hyderabad-Based Virchow Biotech To Produce Sputnik V Vaccine In India
Russian Direct Investment Fund (RDIF) and Hyderabad-based Virchow Biotech on Monday announced an agreement to produce up to 200 million doses of Sputnik V vaccine in India.
-
India's Gland Pharma To Produce Up To 252 Million Doses For Russia's Sputnik V Vaccine
India's Gland Pharma Ltd said on Tuesday it has entered into an agreement with the Russian Direct Investment Fund (RDIF) to produce and supply up to 252 million doses of the Sputnik V COVID-19 vaccine.
-
Russia Expects India To Approve Sputnik V Vaccine For Use Soon: Report
India is expected to grant emergency use authorization for Russia's Sputnik V COVID-19 vaccine this month or next, the Russian Direct Investment Fund (RDIF), which markets the shot abroad, told ANI on Tuesday.
-
Russian Covid Vaccine In Phase 3 Trial, To Cost Less Than $10 Per Dose In India
The Russian COVID-19 vaccine "Sputnik V" will cost less than USD 10 (about Rs 730) per shot in India and the price is the same for all countries, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF) said on Thursday.
-
Sputnik V Can Be "Highly Effective" Against New Covid Strain: Co-Developer
Sputnik V, the world's first COVID-19 vaccine, will be "highly effective" against the new strain of coronavirus found in Europe, said Kirill Dmitriev, Chief Executive Officer (CEO) of Russian Direct Investment Fund, the company which co-developed the vaccine.
